KAI-11101 is the inhibitor for dual leucine zipper kinase ( DLK , MAP3K12 ) with a K i of 0.7 nM. KAI-11101 inhibits Paclitaxel ( HY-B0015 )-induced cJun phosphorylation ( IC 50 =95 nM) and thus inhibits the activation of MAPK pathway. KAI-11101 is blood brain barrier penetrable and can be further investigated for its neuroprotective property.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > MAP3K | Products > Signaling Pathways > p38 MAPK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.